Overall measure of divergence (MD) for each variable sorted in decreasing order of discriminatory power. by Erica Piccirilli (17200066)

Sensitivity analysis between Log-dNLR with cardiovascular and all-cause mortality based on model 3. by Jun Ma (9393)

Decreased SPDL1 expression in the ESCC tissues. by Tao Liu (10785)

The GmNN1/FT2a-GmNFYA-C-GmENOD40 module regulates soybean nodulation. by Xinxin Li (281237)

Immobilization did not significantly influence performance of the right, non-immobilized hand. by Erin M. King (13961547)

Overlap of significant unordered A) and ordered B) comorbidities. by Martina Hall (7829696)

Subjects:

Global Land Use Change Impacts on Soil Nitrogen Availability and Environmental Losses by Jing Wang (6206297)

“…In contrast, reversing managed to natural ecosystems significantly increased NNM by 20% (9.7, 25.4%) and decreased NN by 89% (−125, −46%), indicating increasing N availability while decreasing potential N loss. …”

The global transcription is decreased in VBNC but remains specific. by Benjamin Hommel (523072)

S1 Data - by Mai Ngoc Luu (11868515)

Subjects:

Baseline characteristics of participants. by Mai Ngoc Luu (11868515)

Subjects:

Logistic regression (univariates) and adjusted analysis including the significant covariates from the univariate regression. by Kai Yi Wu (16451082)

Restricted cubic spline curves of SHR with all-cause mortality. by Heshan Cao (17967095)

Subjects:

Kaplan-Meier survival analysis curves for all-cause mortality. by Heshan Cao (17967095)

Subjects:

Trial sequential analysis of all-cause death. by Hong Duo (13302460)

Subjects:

Impaired Ubr5 function results in increased canonical and decreased non-canonical HH signalling. by David Mellis (2833469)

Subgroup analysis of the hazard risks of all-cause cause, CV death, and HHF within an 18-month follow-up period based on intention-to-treat analysis. by Chih-Wei Chen (403470)

HR (95% CI) of all-cause mortality and cause specific mortality according to vitamin D status. by Yan Wang (15435)

Subjects:

Image_3_ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Lea... by Boshen Yang (11935403)

“…A significantly lower all-cause in-hospital mortality was observed among patients treated with ACEI/ARB (3.9 vs. 12.7%) as well as a lower 28-day mortality (3.6 vs. 12.2%). …”

Image_2_ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Lea... by Boshen Yang (11935403)

“…A significantly lower all-cause in-hospital mortality was observed among patients treated with ACEI/ARB (3.9 vs. 12.7%) as well as a lower 28-day mortality (3.6 vs. 12.2%). …”

Image_1_ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Lea... by Boshen Yang (11935403)

“…A significantly lower all-cause in-hospital mortality was observed among patients treated with ACEI/ARB (3.9 vs. 12.7%) as well as a lower 28-day mortality (3.6 vs. 12.2%). …”